Medtronic Cardiac Ablation Solutions

This study tests a new device, the Sphere-9 catheter and Affera ablation system, to treat ventricular tachycardia (VT), a fast and dangerous heart rhythm. About 60 adults with VT caused by heart scarring will receive this treatment. The goal is to see if the device can safely sto…

This study tests a new catheter and mapping system to treat paroxysmal atrial fibrillation, a type of irregular heartbeat. About 100 adults who have not responded to medication will undergo a procedure to isolate the pulmonary veins. The goal is to see if the device is safe and e…

This study is testing a new catheter and ablation system (Sphere-9 and Affera) to treat persistent atrial fibrillation, a type of irregular heartbeat. About 200 adults with this condition will receive the procedure and be followed for 3 years. The goal is to see if the treatment …

This study tests a new device (Sphere-360 catheter and mapping system) to treat paroxysmal atrial fibrillation, a condition where the heart beats irregularly for short periods. About 300 adults with this condition will receive a procedure that uses heat to destroy tiny areas of h…

This study is a global registry that will follow 1,000 adults with arrhythmia (irregular heartbeat) who are treated with the DiamondTemp ablation system. The goal is to see how well the procedure prevents the arrhythmia from coming back and to track any serious side effects over …

This study is a global registry that will follow about 1,950 people with atrial fibrillation who are treated with the PulseSelect PFA system. The goal is to see how well the procedure stops irregular heartbeats and to track any serious side effects related to the device or proced…

This study tests a new catheter system (Sphere-9 and Affera) for a repeat heart ablation procedure in 400 people whose atrial fibrillation (AFib) came back after a first ablation. Participants will have the procedure and be followed for 12 months to see if it safely restores norm…

This study follows 200 people with a type of irregular heartbeat called paroxysmal atrial fibrillation. They will receive a standard treatment using a special freezing catheter to block faulty electrical signals in the heart. Researchers will track how well the procedure prevents…

This study is a global registry that will follow about 540 people with atrial fibrillation who are treated with the Affera ablation system. Researchers want to see how well the system stops irregular heart rhythms and how safe it is in everyday use. Participants must be at least …